|
1
|
Goldstraw P, Ball D, Jett JR, Le Chevalier
T, Lim E, Nicholson AG and Shepherd FA: Non-small-cell lung cancer.
Lancet. 378:1727–1740. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Whitson BA, Groth SS, Duval SJ, Swanson SJ
and Maddaus MA: Surgery for melanoma: A systematic review of the
video-assisted thoracoscopic surgery versus thoracotomy approaches
to lobectomy. Ann Thorac Surg. 86:2008–2016. 2008. View Article : Google Scholar
|
|
3
|
Garbe C, Eigentler TK, Keilholz U,
Hauschild A and Kirkwood JM: Systematic review of medical treatment
in melanoma: Current status and future prospects. Oncologist.
16:5–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le Chevalier T, Arriagada R, Quoix E,
Ruffie P, Martin M, Tarayre M, Lacombe-Terrier MJ, Douillard JY and
Laplanche A: Radiotherapy alone versus combined chemotherapy and
radiotherapy in nonresectable melanoma: First analysis of a
randomized trial in 353 patients. J Natl Cancer Inst. 83:417–423.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Semenza GL: Hypoxia-inducible factor 1:
Master regulator of O2 homeostasis. Curr Opin Genet Dev.
8:588–594. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iyer NV, Kotch LE, Agani F, Leung SW,
Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY
and Semenza GL: Cellular and developmental control of O2
homeostasis by hypoxia-inducible factor 1alpha. Genes Dev.
12:149–162. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhong H, De Marzo AM, Laughner E, Lim M,
Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons
JW: Overexpression of hypoxia-inducible factor 1alpha in common
human cancers and their metastases. Cancer Res. 59:5830–5835.
1999.PubMed/NCBI
|
|
8
|
Greijer AE and van der Wall E: The role of
hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J
Clin Pathol. 57:1009–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Semenza GL: Defining the role of
hypoxia-inducible factor 1 in cancer biology and therapeutics.
Oncogene. 29:625–634. 2010. View Article : Google Scholar :
|
|
10
|
Birner P, Schindl M, Obermair A, Plank C,
Breitenecker G and Oberhuber G: Overexpression of hypoxia-inducible
factor 1alpha is a marker for an unfavorable prognosis in
early-stage invasive cervical cancer. Cancer Res. 60:4693–4696.
2000.PubMed/NCBI
|
|
11
|
Ryan HE, Poloni M, Mc Nulty W, Elson D,
Gassmann M, Arbeit JM and Johnson RS: Hypoxia-inducible
factor-1alpha is a positive factor in solid tumor growth. Cancer
Res. 60:4010–4015. 2000.PubMed/NCBI
|
|
12
|
Eddy SR: Non-coding RNA genes and the
modern RNA world. Nat Rev Genet. 2:919–929. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: MicroRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yiannakopoulou E: Targeting epigenetic
mechanisms and microRNAs by aspirin and other non steroidal
anti-inflammatory agents-implications for cancer treatment and
chemoprevention. Cell Oncol (Dordr). 37:167–178. 2014. View Article : Google Scholar
|
|
18
|
Aprelikova O, Chandramouli GV, Wood M,
Vasselli JR, Riss J, Maranchie JK, Linehan WM and Barrett JC:
Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
J Cell Biochem. 92:491–501. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Semenza GL: Hypoxia-inducible factor 1
(HIF-1) pathway. Sci STKE. 2007:cm82007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuphal S, Winklmeier A, Warnecke C and
Bosserhoff AK: Constitutive HIF-1 activity in malignant melanoma.
Eur J Cancer. 46:1159–1169. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kota J, Chivukula RR, O'Donnell KA,
Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P,
Torbenson M, Clark KR, et al: Therapeutic microRNA delivery
suppresses tumorigenesis in a murine liver cancer model. Cell.
137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bader AG, Brown D and Winkler M: The
promise of microRNA replacement therapy. Cancer Res. 70:7027–7030.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lanford RE, Hildebrandt-Eriksen ES, Petri
A, Persson R, Lindow M, Munk ME, Kauppinen S and Ørum H:
Therapeutic silencing of microRNA-122 in primates with chronic
hepatitis C virus infection. Science. 327:198–201. 2010. View Article : Google Scholar
|
|
27
|
Cowland JB, Hother C and Grønbaek K:
MicroRNAs and cancer. APMIS. 115:1090–1106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakurai K, Furukawa C, Haraguchi T, Inada
K, Shiogama K, Tagawa T, Fujita S, Ueno Y, Ogata A, Ito M, et al:
MicroRNAs miR-199a-5p and-3p target the Brm subunit of SWI/SNF to
generate a double-negative feedback loop in a variety of human
cancers. Cancer Res. 71:1680–1689. 2011. View Article : Google Scholar
|
|
29
|
Shen Q, Cicinnati VR, Zhang X, Iacob S,
Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G and
Beckebaum S: Role of microRNA-199a-5p and discoidin domain receptor
1 in human hepatocellular carcinoma invasion. Mol Cancer.
9:2272010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rane S, He M, Sayed D, Yan L, Vatner D and
Abdellatif M: An antagonism between the AKT and beta-adrenergic
signaling pathways mediated through their reciprocal effects on
miR-199a-5p. Cell Signal. 22:1054–1062. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yi H, Liang B, Jia J, Liang N, Xu H, Ju G,
Ma S and Liu X: Differential roles of miR-199a-5p in
radiation-induced autophagy in breast cancer cells. FEBS Lett.
587:436–443. 2013. View Article : Google Scholar : PubMed/NCBI
|
